Crossmark

Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy

Published Online: 2016-08-25

Published Print: 2016-12

Authors

Tabchi, Samer

Kourie, Hampig Raphael

Kattan, Joseph
License Information

Text and Data Mining valid from 2016-08-25

Version of Record valid from 2016-08-25
More Information

Article History

Received: 15 July 2016

Accepted: 9 August 2016

First Online: 25 August 2016

Compliance with ethical standards

:

: The authors confirm that they do not have any conflict of interest.

Document is current